Pricing Log in Create free account

SCYNEXIS, Inc. (SCYX) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

SCYNEXIS, Inc. and Shuttle Pharmaceuticals Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $32.8M against $24.0M — 1.4× the size. Shuttle Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (−36.7% vs −110.7%). Across the 13 metrics below, Shuttle Pharmaceuticals Holdings, Inc. leads on 7 and SCYNEXIS, Inc. on 6.

Valuation

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.91 n/m 2.08
P/B 0.59 0.27 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.54 n/m 2.87
Earnings yield (62.76%) (533.70%) (15.94%)
Free cash flow yield (33.85%) (128.57%) 0.00%

Profitability

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 0.00% 53.51%
Operating margin (109.90%) 0.00% 0.00%
Net margin (49.74%) 0.00% (2.45%)
Free cash flow margin (64.67%) 0.00% 0.00%
Return on equity (18.38%) (90.05%) (0.80%)
Return on assets (15.09%) (72.47%) (1.67%)
Return on invested capital (110.72%) (36.73%) 0.00%

Growth

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 682.47% — 5.22%
EPS growth (last fiscal year) 61.36% 91.32% 42.91%
Revenue growth, 5-year CAGR 179.40% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 9.65 0.11 2.41
Net debt to EBITDA 2.54 0.03 1.01

Dividend

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric SCYX SHPH Drug Manufacturers Specialty & Generic median
Market cap 32.84m 24.01m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack